| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/31/2011 | CN102166353A A spray for treating diseases caused by human papilloma viruses and a preparation method |
| 08/31/2011 | CN102166352A Preparation method of swine influenza bivalent inactivated vaccine and product of swine influenza bivalent inactivated vaccine |
| 08/31/2011 | CN102166351A H1N1 influenza A vaccine and application thereof |
| 08/31/2011 | CN102166350A Flounders quintuplet inactivated vaccine and preparation method thereof |
| 08/31/2011 | CN102166349A Malaria infrared stage DNA vaccine and preparing method thereof |
| 08/31/2011 | CN102166348A Application of inhibin recombinant fusion protein to preparing medicines for promoting oestrus and hybridization of sows |
| 08/31/2011 | CN102166228A A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |
| 08/31/2011 | CN101492495B A group of antigen epitope polypeptide and uses thereof |
| 08/31/2011 | CN101474401B Method for producing concentrated inactivate vaccine for newcastle disease |
| 08/31/2011 | CN101450208B Nasal-spraying immune influenza multivalent vaccine preparation method |
| 08/31/2011 | CN101406699B Method for preparing lyophilized hepatitis A attenuated live vaccine using cell factory |
| 08/31/2011 | CN101401939B Anti-activated state T cell antibody vaccine for preventing and/or treating immune correlated disease |
| 08/31/2011 | CN101080227B Combinations of therapeutic agents for treating cancer |
| 08/30/2011 | US8010298 Identifying antigen clusters for monitoring a global state of an immune system |
| 08/30/2011 | US8008460 Polynucleotide fragments of an infectious human endogenous retrovirus |
| 08/30/2011 | US8008450 Therapeutic use of anti-CS1 antibodies |
| 08/30/2011 | US8008442 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
| 08/30/2011 | US8008323 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 08/30/2011 | US8008266 Nucleic acids containing unmethylated cytosine-guanine dinucleotides activate lymphocytes and redirect an immune response from th2 to th1 |
| 08/30/2011 | US8008265 Vaccines, immunotherapeutics and methods for using the same |
| 08/30/2011 | US8008257 ANF fusion proteins |
| 08/30/2011 | US8008092 CCR3 inhibition for ocular angiogenesis and macular degeneration |
| 08/30/2011 | US8008077 Photochemical internalization for delivery of molecules into the cytosol |
| 08/30/2011 | US8008076 Method of producing a nucleic acid encoding an antibody |
| 08/30/2011 | US8008004 Compositions and methods for the diagnosis and treatment of tumors of glial origin |
| 08/30/2011 | US8008000 Viral variants detection and application |
| 08/30/2011 | US8007999 Real-time detection of influenza virus |
| 08/30/2011 | US8007997 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 08/30/2011 | US8007828 implants containing a neurotoxin with sustained biological activity would manifest as improved patient compliance, increased quality of life, improved therapeutic outcome and a reduced incidence of side effects and complications |
| 08/30/2011 | US8007818 Polyanionic polymer adjuvants for haemophilus influenzae B saccharide vaccines |
| 08/30/2011 | US8007817 Compositions and methods for treating microbial infections |
| 08/30/2011 | US8007816 Yeast-based therapeutic for chronic hepatitis C infection |
| 08/30/2011 | US8007815 Combination meningitidis B/C vaccines |
| 08/30/2011 | US8007812 Flagellin related polypeptides and uses thereof |
| 08/30/2011 | US8007811 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
| 08/30/2011 | US8007810 HLA-A2 tumor associated antigen peptides and compositions |
| 08/30/2011 | US8007809 Activin-actrii antagonists and uses for increasing red blood cell levels |
| 08/30/2011 | US8007808 Composition and method for facilitating the internalization of a therapeutic agent into a cell |
| 08/30/2011 | US8007807 Multiple vaccination including serogroup C meningococcus |
| 08/30/2011 | US8007806 Vaccine composition comprising a fibronectin binding protein or a fibronectin binding peptide |
| 08/30/2011 | US8007805 Chimeric antigens for breaking host tolerance to foreign antigens |
| 08/30/2011 | US8007804 Complement receptor 2 targeted complement modulators |
| 08/30/2011 | US8007803 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
| 08/30/2011 | US8007800 Methods for treating bone cancer pain by administering a nerve growth factor antagonist antibody |
| 08/30/2011 | US8007799 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/30/2011 | US8007798 Treatment of complement-associated disorders |
| 08/30/2011 | US8007797 Junctional adhesion molecule-C (JAM-C) binding compounds and methods of their use |
| 08/30/2011 | US8007796 Means and methods for the treatment of tumorous diseases |
| 08/30/2011 | US8007795 Anti-tissue factor antibodies and methods of use thereof |
| 08/30/2011 | US8007794 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| 08/30/2011 | US8007793 Stabilized liquid anti-RSV antibody formulations |
| 08/30/2011 | US8007792 Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions |
| 08/30/2011 | US8007791 Prevention and treatment of complement-associated eye conditions |
| 08/30/2011 | US8007790 Using modulator of tumor necrosis factor (TNF) pathway such as infliximab, simvastatin; drug screening |
| 08/30/2011 | US8007781 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen |
| 08/30/2011 | US8007776 Vaccine composition comprising interleukin-15 (IL-15) |
| 08/30/2011 | US8007770 Purified linear polypeptide epitopes from walnuts and associated methods |
| 08/30/2011 | US8007718 System for and method of processing bone material using supercritical fluids |
| 08/30/2011 | CA2605029C Leptospirosis culture process |
| 08/30/2011 | CA2472293C Use of tyrosine kinase inhibitors for the treatment of inflammatory processes |
| 08/30/2011 | CA2436407C Polymer conjugates of neublastin and methods of using same |
| 08/30/2011 | CA2405458C Herpes viruses for immune modulation |
| 08/30/2011 | CA2331329C Diacylglycerol acyl transferase proteins |
| 08/30/2011 | CA2288962C Human monoclonal antibodies to epidermal growth factor receptor |
| 08/30/2011 | CA2190473C Recombinant papilloma virus l1 |
| 08/25/2011 | WO2011103588A1 Polysaccharide particle vaccines |
| 08/25/2011 | WO2011103490A2 INTEGRIN αVβ8 NEUTRALIZING ANTIBODY |
| 08/25/2011 | WO2011103465A2 Botulinum neurotoxin antigenic compositions and methods |
| 08/25/2011 | WO2011103458A2 Compositions and methods for using and identifying antimicrobial agents |
| 08/25/2011 | WO2011103453A2 Vaccines for use in the prophylaxis and treatment of influenza virus disease |
| 08/25/2011 | WO2011103417A2 Vectors expressing hiv antigens and gm-csf and related methods for generating an immune response |
| 08/25/2011 | WO2011103389A1 Method to treat autoimmune demyelinating diseases and other autoimmune or inflammatory diseases |
| 08/25/2011 | WO2011103330A2 Novel phosphorylation of cardiac troponin i as a monitor for cardiac injury |
| 08/25/2011 | WO2011103242A1 Neuregulin antagonists and use thereof in treating cancer |
| 08/25/2011 | WO2011103028A2 Compositions and methods for inhibiting mmset |
| 08/25/2011 | WO2011102999A2 Spink1 targeted therapy |
| 08/25/2011 | WO2011102900A1 Universal virus-like particle (vlp) influenza vaccines |
| 08/25/2011 | WO2011102845A1 Rage fusion protein compositions and methods of use |
| 08/25/2011 | WO2011102556A1 Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosa |
| 08/25/2011 | WO2011102555A1 Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosa |
| 08/25/2011 | WO2011102554A1 Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa |
| 08/25/2011 | WO2011102553A1 Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa |
| 08/25/2011 | WO2011102552A1 Antibody against a band lipopolysaccharide of pseudomonas aeruginosa |
| 08/25/2011 | WO2011102551A1 Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa |
| 08/25/2011 | WO2011102517A1 Antiviral agent, abzyme, primer set, method for producing polynucleotide, and method for producing polypeptide |
| 08/25/2011 | WO2011102483A1 HUMAN LAP TGF-β BINDING ANTIBODY |
| 08/25/2011 | WO2011102407A1 Radiation therapy agent |
| 08/25/2011 | WO2011101790A1 Antigenic polypeptides of trichinella and uses thereof |
| 08/25/2011 | WO2011101634A2 Methods |
| 08/25/2011 | WO2011101465A1 Ic31 nanoparticles |
| 08/25/2011 | WO2011101435A1 Activatable constructs |
| 08/25/2011 | WO2011101328A2 Treatment with a humanized igg class anti egfr antibody and an antibody against insulin like growth factor 1 receptor |
| 08/25/2011 | WO2011101173A1 Polypeptides |
| 08/25/2011 | WO2011100786A1 Compositions and methods for targeting type 1 interferon producing cells |
| 08/25/2011 | WO2011075822A8 Immunogenic compositions and related methods |
| 08/25/2011 | WO2011032161A3 Vaccines directed to langerhans cells |
| 08/25/2011 | WO2010115118A3 Methods for preparing and using multichaperone-antigen complexes |
| 08/25/2011 | US20110209248 Novel sugar transporters |
| 08/25/2011 | US20110208673 Antibodies to lymphotoxin-alpha |
| 08/25/2011 | US20110208168 Particle formulations for use in pharmaceutical compositions |